2-methyl-thieno-benzodiazepine formulation
US7303764B2 · kind B2 · utility
4Cited by
23References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 3, 2003 |
| Grant date | Dec 4, 2007 |
| Priority date | — |
| Expiry date | Dec 27, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/38
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.